Apellis Pharmaceuticals Enters Capped Royalty Purchase Agreement with Sobi for Aspaveli

WilmerHale has advised Apellis Pharmaceuticals on the deal.Apellis Pharmaceuticals, Inc., a global biopharmaceutical company, has announced the execution of a capped royalty purchase agreement with Swedish…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here